Study highlights potential of p-tau217 assays in Alzheimer’s clinical trials and diagnosis Post author: Post published:March 14, 2024 Post category:uncategorized The performance of two commercial phospho-tau217 (p-tau217) assays. You Might Also Like Meet Wanda: The AI-generated influencer spreading cancer prevention messages January 20, 2025 New approach detects T cells in “cold” tumors, paves way for broader immunotherapy February 29, 2024 VALANX Biotech and Fina Biosolutions Introduce ClickCRM for Rapid Conjugate Vaccine Development October 31, 2024
VALANX Biotech and Fina Biosolutions Introduce ClickCRM for Rapid Conjugate Vaccine Development October 31, 2024